Skip to main content
Top
Published in: Tumor Biology 1/2010

01-01-2010 | Research Article

Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and β1 integrin

Authors: Adriane S. Siqueira, Letícia N. Gama-de-Souza, Maria Vanda C. Arnaud, João J. V. Pinheiro, Ruy G. Jaeger

Published in: Tumor Biology | Issue 1/2010

Login to get access

Abstract

Squamous cell carcinoma is a prevalent head and neck tumor with high mortality. We studied the role played by laminin α1 chain peptide AG73 on migration, invasion, and protease activity of cells (OSCC) from human oral squamous cell carcinoma. Immunohistochemistry and immunofluorescence analyzed expression of laminin α1 chain and MMP9 in oral squamous cells carcinoma in vivo and in vitro. Migratory activity of AG73-treated OSCC cells was investigated by monolayer wound assays and in chemotaxis chambers. AG73-induced invasion was assessed in Boyden chambers. Invasion depends on MMPs. Conditioned media from cells grown on AG73 was subjected to zymography. We searched for AG73 receptors related to these activities in OSCC cells. Immunofluorescence analyzed AG73-induced colocalization of syndecan-1 and β1 integrin. Cells had these receptors silenced by siRNA, followed by treatment with AG73 and analysis of migration, invasion, and protease activity. Oral squamous cell carcinoma expresses laminin α1 chain and MMP9. OSCC cells treated with AG73 showed increased migration, invasion, and protease activity. AG73 induced colocalization of syndecan-1 and β1 integrin. Knockdown of these receptors decreased AG73-dependent migration, invasion, and protease activity. Syndecan-1 and β1 integrin signaling downstream of AG73 regulate migration, invasion, and MMP production by OSCC cells.
Literature
1.
go back to reference McDowell JD. An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin North Am. 2006;39:277–94.CrossRefPubMed McDowell JD. An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin North Am. 2006;39:277–94.CrossRefPubMed
2.
go back to reference Mehrotra R, Yadav S. Oral squamous cell carcinoma: etiology, pathogenesis and prognostic value of genomic alterations. Indian J Cancer. 2006;43:60–6.CrossRefPubMed Mehrotra R, Yadav S. Oral squamous cell carcinoma: etiology, pathogenesis and prognostic value of genomic alterations. Indian J Cancer. 2006;43:60–6.CrossRefPubMed
3.
go back to reference Bsoul SA, Huber MA, Terezhalmy GT. Squamous cell carcinoma of the oral tissues: a comprehensive review for oral healthcare providers. J Contemp Dent Pract. 2005;6:1–16. Bsoul SA, Huber MA, Terezhalmy GT. Squamous cell carcinoma of the oral tissues: a comprehensive review for oral healthcare providers. J Contemp Dent Pract. 2005;6:1–16.
4.
go back to reference Atula T, Hedstrom J, Finne P, Leivo I, Markkanen-Leppanen M, Haglund C. Tenascin-c expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma. Anticancer Res. 2003;23:3051–6.PubMed Atula T, Hedstrom J, Finne P, Leivo I, Markkanen-Leppanen M, Haglund C. Tenascin-c expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma. Anticancer Res. 2003;23:3051–6.PubMed
5.
go back to reference de Vicente JC, Fresno MF, Villalain L, Vega JA, Lopez Arranz JS. Immunoexpression and prognostic significance of timp-1 and -2 in oral squamous cell carcinoma. Oral Oncol. 2005;41:568–79.CrossRefPubMed de Vicente JC, Fresno MF, Villalain L, Vega JA, Lopez Arranz JS. Immunoexpression and prognostic significance of timp-1 and -2 in oral squamous cell carcinoma. Oral Oncol. 2005;41:568–79.CrossRefPubMed
6.
go back to reference Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA, et al. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology. 2007;51:849–53.CrossRefPubMed Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA, et al. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology. 2007;51:849–53.CrossRefPubMed
7.
8.
go back to reference Kleinman HK, Weeks BS, Schnaper HW, Kibbey MC, Yamamura K, Grant DS. The laminins: a family of basement membrane glycoproteins important in cell differentiation and tumor metastases. Vitam Horm. 1993;47:161–86.CrossRefPubMed Kleinman HK, Weeks BS, Schnaper HW, Kibbey MC, Yamamura K, Grant DS. The laminins: a family of basement membrane glycoproteins important in cell differentiation and tumor metastases. Vitam Horm. 1993;47:161–86.CrossRefPubMed
9.
go back to reference Capuano AC, Jaeger RG. The effect of laminin and its peptide sikvav on a human salivary gland myoepithelioma cell line. Oral Oncol. 2004;40:36–42.CrossRefPubMed Capuano AC, Jaeger RG. The effect of laminin and its peptide sikvav on a human salivary gland myoepithelioma cell line. Oral Oncol. 2004;40:36–42.CrossRefPubMed
10.
go back to reference de Oliveira PT, Jaeger MM, Miyagi SP, Jaeger RG. The effect of a reconstituted basement membrane (matrigel) on a human salivary gland myoepithelioma cell line. Virchows Arch. 2001;439:571–8.CrossRefPubMed de Oliveira PT, Jaeger MM, Miyagi SP, Jaeger RG. The effect of a reconstituted basement membrane (matrigel) on a human salivary gland myoepithelioma cell line. Virchows Arch. 2001;439:571–8.CrossRefPubMed
11.
go back to reference Freitas VM, Jaeger RG. The effect of laminin and its peptide sikvav on a human salivary gland adenoid cystic carcinoma cell line. Virchows Arch. 2002;441:569–76.CrossRefPubMed Freitas VM, Jaeger RG. The effect of laminin and its peptide sikvav on a human salivary gland adenoid cystic carcinoma cell line. Virchows Arch. 2002;441:569–76.CrossRefPubMed
12.
go back to reference Freitas VM, Scheremeta B, Hoffman MP, Jaeger RG. Laminin-1 and sikvav a laminin-1-derived peptide, regulate the morphology and protease activity of a human salivary gland adenoid cystic carcinoma cell line. Oral Oncol. 2004;40:483–9.CrossRefPubMed Freitas VM, Scheremeta B, Hoffman MP, Jaeger RG. Laminin-1 and sikvav a laminin-1-derived peptide, regulate the morphology and protease activity of a human salivary gland adenoid cystic carcinoma cell line. Oral Oncol. 2004;40:483–9.CrossRefPubMed
13.
go back to reference Freitas VM, Vilas-Boas VF, Pimenta DC, Loureiro V, Juliano MA, Carvalho MR, et al. Sikvav, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the erk 1/2 signaling pathway. Am J Pathol. 2007;171:124–38.CrossRefPubMed Freitas VM, Vilas-Boas VF, Pimenta DC, Loureiro V, Juliano MA, Carvalho MR, et al. Sikvav, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the erk 1/2 signaling pathway. Am J Pathol. 2007;171:124–38.CrossRefPubMed
14.
go back to reference Gama-de-Souza LN, Cyreno-Oliveira E, Freitas VM, Melo ES, Vilas-Boas VF, Moriscot AS, et al. Adhesion and protease activity in cell lines from human salivary gland tumors are regulated by the laminin-derived peptide ag73, syndecan-1 and beta1 integrin. Matrix Biol. 2008;27:402–19.CrossRefPubMed Gama-de-Souza LN, Cyreno-Oliveira E, Freitas VM, Melo ES, Vilas-Boas VF, Moriscot AS, et al. Adhesion and protease activity in cell lines from human salivary gland tumors are regulated by the laminin-derived peptide ag73, syndecan-1 and beta1 integrin. Matrix Biol. 2008;27:402–19.CrossRefPubMed
15.
go back to reference Jaeger RG, Scarabotto-Neto N, Azambuja N Jr, Freitas VM. Secretion of collagen i and tenascin is modulated by laminin-111 in 3d culture of human adenoid cystic carcinoma cells. Int J Exp Pathol. 2008;89:98–105.CrossRefPubMed Jaeger RG, Scarabotto-Neto N, Azambuja N Jr, Freitas VM. Secretion of collagen i and tenascin is modulated by laminin-111 in 3d culture of human adenoid cystic carcinoma cells. Int J Exp Pathol. 2008;89:98–105.CrossRefPubMed
16.
go back to reference Morais Freitas V, Nogueira da Gama de Souza L, Cyreno Oliveira E, Furuse C, Cavalcanti de Araujo V, Gastaldoni Jaeger R. Malignancy-related 67 kda laminin receptor in adenoid cystic carcinoma. Effect on migration and beta-catenin expression. Oral Oncol. 2007;43:987–98.CrossRefPubMed Morais Freitas V, Nogueira da Gama de Souza L, Cyreno Oliveira E, Furuse C, Cavalcanti de Araujo V, Gastaldoni Jaeger R. Malignancy-related 67 kda laminin receptor in adenoid cystic carcinoma. Effect on migration and beta-catenin expression. Oral Oncol. 2007;43:987–98.CrossRefPubMed
17.
go back to reference Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, et al. A simplified laminin nomenclature. Matrix Biol. 2005;24:326–32.CrossRefPubMed Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, et al. A simplified laminin nomenclature. Matrix Biol. 2005;24:326–32.CrossRefPubMed
18.
go back to reference Colognato H, Yurchenco PD. Form and function: the laminin family of heterotrimers. Dev Dyn. 2000;218:213–34.CrossRefPubMed Colognato H, Yurchenco PD. Form and function: the laminin family of heterotrimers. Dev Dyn. 2000;218:213–34.CrossRefPubMed
19.
go back to reference Faisal Khan KM, Laurie GW, McCaffrey TA, Falcone DJ. Exposure of cryptic domains in the alpha 1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression. J Biol Chem. 2002;277:13778–86.CrossRefPubMed Faisal Khan KM, Laurie GW, McCaffrey TA, Falcone DJ. Exposure of cryptic domains in the alpha 1-chain of laminin-1 by elastase stimulates macrophages urokinase and matrix metalloproteinase-9 expression. J Biol Chem. 2002;277:13778–86.CrossRefPubMed
20.
go back to reference Schenk S, Quaranta V. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol. 2003;13:366–75.CrossRefPubMed Schenk S, Quaranta V. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol. 2003;13:366–75.CrossRefPubMed
21.
go back to reference Hoffman MP, Nomizu M, Roque E, Lee S, Jung DW, Yamada Y, et al. Laminin-1 and laminin-2g-domain synthetic peptides bind syndecan-1 and are involved in acinar formation of a human submandibular gland cell line. J Biol Chem. 1998;273:28633–41.CrossRefPubMed Hoffman MP, Nomizu M, Roque E, Lee S, Jung DW, Yamada Y, et al. Laminin-1 and laminin-2g-domain synthetic peptides bind syndecan-1 and are involved in acinar formation of a human submandibular gland cell line. J Biol Chem. 1998;273:28633–41.CrossRefPubMed
22.
go back to reference Nomizu M, Kim WH, Yamamura K, Utani A, Song SY, Otaka A, et al. Identification of cell binding sites in the laminin alpha 1 chain carboxyl-terminal globular domain by systematic screening of synthetic peptides. J Biol Chem. 1995;270:20583–90.CrossRefPubMed Nomizu M, Kim WH, Yamamura K, Utani A, Song SY, Otaka A, et al. Identification of cell binding sites in the laminin alpha 1 chain carboxyl-terminal globular domain by systematic screening of synthetic peptides. J Biol Chem. 1995;270:20583–90.CrossRefPubMed
23.
go back to reference Suzuki N, Yokoyama F, Nomizu M. Functional sites in the laminin alpha chains. Connect Tissue Res. 2005;46:142–52.CrossRefPubMed Suzuki N, Yokoyama F, Nomizu M. Functional sites in the laminin alpha chains. Connect Tissue Res. 2005;46:142–52.CrossRefPubMed
24.
go back to reference Kim WH, Nomizu M, Song SY, Tanaka K, Kuratomi Y, Kleinman HK, et al. Laminin-alpha1-chain sequence leu-gln-val-gln-leu-ser-ile-arg (lqvqlsir) enhances murine melanoma cell metastases. Int J Cancer. 1998;77:632–9.CrossRefPubMed Kim WH, Nomizu M, Song SY, Tanaka K, Kuratomi Y, Kleinman HK, et al. Laminin-alpha1-chain sequence leu-gln-val-gln-leu-ser-ile-arg (lqvqlsir) enhances murine melanoma cell metastases. Int J Cancer. 1998;77:632–9.CrossRefPubMed
25.
go back to reference Mochizuki M, Philp D, Hozumi K, Suzuki N, Yamada Y, Kleinman HK, et al. Angiogenic activity of syndecan-binding laminin peptide ag73 (rkrlqvqlsirt). Arch Biochem Biophys. 2007;459:249–55.CrossRefPubMed Mochizuki M, Philp D, Hozumi K, Suzuki N, Yamada Y, Kleinman HK, et al. Angiogenic activity of syndecan-binding laminin peptide ag73 (rkrlqvqlsirt). Arch Biochem Biophys. 2007;459:249–55.CrossRefPubMed
26.
go back to reference Song SY, Nomizu M, Yamada Y, Kleinman HK. Liver metastasis formation by laminin-1 peptide (lqvqlsir)-adhesion selected b16–f10 melanoma cells. Int J Cancer. 1997;71:436–41.CrossRefPubMed Song SY, Nomizu M, Yamada Y, Kleinman HK. Liver metastasis formation by laminin-1 peptide (lqvqlsir)-adhesion selected b16–f10 melanoma cells. Int J Cancer. 1997;71:436–41.CrossRefPubMed
27.
go back to reference Lee EJ, Kim J, Lee SA, Kim EJ, Chun YC, Ryu MH, et al. Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med. 2005;37:379–90.PubMed Lee EJ, Kim J, Lee SA, Kim EJ, Chun YC, Ryu MH, et al. Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med. 2005;37:379–90.PubMed
28.
go back to reference Freitas VM, Rangel M, Bisson LF, Jaeger RG, Machado-Santelli GM. The geodiamolide h, derived from brazilian sponge geodia corticostylifera, regulates actin cytoskeleton, migration and invasion of breast cancer cells cultured in three-dimensional environment. J Cell Physiol. 2008;216:583–94.CrossRefPubMed Freitas VM, Rangel M, Bisson LF, Jaeger RG, Machado-Santelli GM. The geodiamolide h, derived from brazilian sponge geodia corticostylifera, regulates actin cytoskeleton, migration and invasion of breast cancer cells cultured in three-dimensional environment. J Cell Physiol. 2008;216:583–94.CrossRefPubMed
29.
go back to reference Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221–33.CrossRefPubMed Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221–33.CrossRefPubMed
30.
go back to reference Wilson DF, Jiang DJ, Pierce AM, Wiebkin OW. Oral cancer: role of the basement membrane in invasion. Aust Dent J. 1999;44:93–7.CrossRefPubMed Wilson DF, Jiang DJ, Pierce AM, Wiebkin OW. Oral cancer: role of the basement membrane in invasion. Aust Dent J. 1999;44:93–7.CrossRefPubMed
31.
go back to reference Graf J, Ogle RC, Robey FA, Sasaki M, Martin GR, Yamada Y, et al. A pentapeptide from the laminin b1 chain mediates cell adhesion and binds the 67, 000 laminin receptor. Biochemistry. 1987;26:6896–900.CrossRefPubMed Graf J, Ogle RC, Robey FA, Sasaki M, Martin GR, Yamada Y, et al. A pentapeptide from the laminin b1 chain mediates cell adhesion and binds the 67, 000 laminin receptor. Biochemistry. 1987;26:6896–900.CrossRefPubMed
32.
go back to reference Skubitz AP, McCarthy JB, Zhao Q, Yi XY, Furcht LT. Definition of a sequence, RYVVLPR, within laminin peptide f-9 that mediates metastatic fibrosarcoma cell adhesion and spreading. Cancer Res. 1990;50:7612–22.PubMed Skubitz AP, McCarthy JB, Zhao Q, Yi XY, Furcht LT. Definition of a sequence, RYVVLPR, within laminin peptide f-9 that mediates metastatic fibrosarcoma cell adhesion and spreading. Cancer Res. 1990;50:7612–22.PubMed
33.
go back to reference Ponce ML, Kleinman HK. Identification of redundant angiogenic sites in laminin alpha1 and gamma1 chains. Exp Cell Res. 2003;285:189–95.CrossRefPubMed Ponce ML, Kleinman HK. Identification of redundant angiogenic sites in laminin alpha1 and gamma1 chains. Exp Cell Res. 2003;285:189–95.CrossRefPubMed
34.
go back to reference Hozumi K, Suzuki N, Nielsen PK, Nomizu M, Yamada Y. Laminin alpha1 chain lg4 module promotes cell attachment through syndecans and cell spreading through integrin alpha2beta1. J Biol Chem. 2006;281:32929–40.CrossRefPubMed Hozumi K, Suzuki N, Nielsen PK, Nomizu M, Yamada Y. Laminin alpha1 chain lg4 module promotes cell attachment through syndecans and cell spreading through integrin alpha2beta1. J Biol Chem. 2006;281:32929–40.CrossRefPubMed
35.
36.
go back to reference Pinheiro JJ, Freitas VM, Moretti AI, Jorge AG, Jaeger RG. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology. 2004;45:65–72.CrossRefPubMed Pinheiro JJ, Freitas VM, Moretti AI, Jorge AG, Jaeger RG. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology. 2004;45:65–72.CrossRefPubMed
37.
go back to reference Patarroyo M, Tryggvason K, Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol. 2002;12:197–207.CrossRefPubMed Patarroyo M, Tryggvason K, Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol. 2002;12:197–207.CrossRefPubMed
38.
go back to reference Shinohara M, Nakamura S, Sasaki M, Kurahara S, Ikebe T, Harada T, et al. Expression of integrins in squamous cell carcinoma of the oral cavity. Correlations with tumor invasion and metastasis. Am J Clin Pathol. 1999;111:75–88.PubMed Shinohara M, Nakamura S, Sasaki M, Kurahara S, Ikebe T, Harada T, et al. Expression of integrins in squamous cell carcinoma of the oral cavity. Correlations with tumor invasion and metastasis. Am J Clin Pathol. 1999;111:75–88.PubMed
39.
go back to reference Thorup AK, Reibel J, Schiodt M, Stenersen TC, Therkildsen MH, Carter WG, et al. Can alterations in integrin and laminin-5 expression be used as markers of malignancy? APMIS. 1998;106:1170–80.CrossRefPubMed Thorup AK, Reibel J, Schiodt M, Stenersen TC, Therkildsen MH, Carter WG, et al. Can alterations in integrin and laminin-5 expression be used as markers of malignancy? APMIS. 1998;106:1170–80.CrossRefPubMed
40.
go back to reference Zhang K, Kim JP, Woodley DT, Waleh NS, Chen YQ, Kramer RH. Restricted expression and function of laminin 1-binding integrins in normal and malignant oral mucosal keratinocytes. Cell Adhes Commun. 1996;4:159–74.CrossRefPubMed Zhang K, Kim JP, Woodley DT, Waleh NS, Chen YQ, Kramer RH. Restricted expression and function of laminin 1-binding integrins in normal and malignant oral mucosal keratinocytes. Cell Adhes Commun. 1996;4:159–74.CrossRefPubMed
41.
go back to reference Beauvais DM, Burbach BJ, Rapraeger AC. The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol. 2004;167:171–81.CrossRefPubMed Beauvais DM, Burbach BJ, Rapraeger AC. The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol. 2004;167:171–81.CrossRefPubMed
42.
go back to reference Humphries MJ, Mostafavi-Pour Z, Morgan MR, Deakin NO, Messent AJ, Bass MD. Integrin-syndecan cooperation governs the assembly of signalling complexes during cell spreading. Novartis Found Symp. 2005;269:178–88. discussion 188-192, 223-130.CrossRefPubMed Humphries MJ, Mostafavi-Pour Z, Morgan MR, Deakin NO, Messent AJ, Bass MD. Integrin-syndecan cooperation governs the assembly of signalling complexes during cell spreading. Novartis Found Symp. 2005;269:178–88. discussion 188-192, 223-130.CrossRefPubMed
43.
go back to reference Ghosh S, Stack MS. Proteolytic modification of laminins: functional consequences. Microsc Res Tech. 2000;51:238–46.CrossRefPubMed Ghosh S, Stack MS. Proteolytic modification of laminins: functional consequences. Microsc Res Tech. 2000;51:238–46.CrossRefPubMed
Metadata
Title
Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and β1 integrin
Authors
Adriane S. Siqueira
Letícia N. Gama-de-Souza
Maria Vanda C. Arnaud
João J. V. Pinheiro
Ruy G. Jaeger
Publication date
01-01-2010
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 1/2010
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-009-0008-x

Other articles of this Issue 1/2010

Tumor Biology 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine